Kura Oncology, Inc.
DE ˙ DB ˙ US50127T1097
€ 7,56 ↑0.24 (3.28%)
2026-06-05
PREÇO DA AÇÃO
SecurityDE:KUR / Kura Oncology, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership1,040,233 shares
Latest Disclosed Value $ 8,457,094
UBS Group AG reports 1.87% decrease in ownership of KUR / Kura Oncology, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 1,040,233 shares of Kura Oncology, Inc. (DE:KUR) valued at $6,917,549 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 1,060,025 shares of Kura Oncology, Inc.. This represents a change in shares of -1.87% during the quarter. The current value of the position is $7,864,161 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F KURA ONCOLOGY COM 50127T109 1,040,233 -19,792 -1.87 8,457 -23.21 0.0002
2026-01-29 2025-12-31 13F KURA ONCOLOGY COM 50127T109 1,060,025 574,455 118.31 11,014 156.30 0.0003
2025-11-13 2025-09-30 13F KURA ONCOLOGY COM 50127T109 485,570 373,287 332.45 4,297 564.14 0.0007
2025-08-14 2025-06-30 13F KURA ONCOLOGY COM 50127T109 112,283 -27,242 -19.52 648 -29.67 0.0001
2025-05-13 2025-03-31 13F KURA ONCOLOGY COM 50127T109 139,525 -175,950 -55.77 921 -66.51 0.0002
2025-02-14 2024-12-31 13F KURA ONCOLOGY COM 50127T109 315,475 185,659 143.02 2,748 8.32 0.0005
2024-11-14 2024-09-30 13F KURA ONCOLOGY COM 50127T109 129,816 38,039 41.45 2,537 34.25 0.0006
2024-08-14 2024-06-30 13F KURA ONCOLOGY COM 50127T109 91,777 -135,044 -59.54 1,890 -60.95 0.0005
2024-05-13 2024-03-31 13F KURA ONCOLOGY COM 50127T109 226,821 23,864 11.76 4,838 65.80 0.0012
2024-02-09 2023-12-31 13F KURA ONCOLOGY COM 50127T109 202,957 120,612 146.47 2,919 289.07 0.0009
2023-11-09 2023-09-30 13F KURA ONCOLOGY COM 50127T109 82,345 82,328 484,282.35 751 0.0003
2023-08-11 2023-06-30 13F KURA ONCOLOGY COM 50127T109 17 -214,123 -99.99 0 -100.00 0.0000
2023-05-12 2023-03-31 13F KURA ONCOLOGY COM 50127T109 214,140 -796 -0.37 2,619 -1.84 0.0010
2023-02-08 2022-12-31 13F KURA ONCOLOGY COM 50127T109 214,936 181,705 546.79 2,667 487.44 0.0010
2022-11-10 2022-09-30 13F KURA ONCOLOGY COM 50127T109 33,231 -28,017 -45.74 454 -59.57 0.0002
2022-08-10 2022-06-30 13F KURA ONCOLOGY COM 50127T109 61,248 -127,571 -67.56 1,123 -63.01 0.0005
2022-05-16 2022-03-31 13F KURA ONCOLOGY COM 50127T109 188,819 24,012 14.57 3,036 31.60 0.0010
2022-02-14 2021-12-31 13F KURA ONCOLOGY COM 50127T109 164,807 153,363 1,340.12 2,307 978.04 0.0007
2021-11-15 2021-09-30 13F KURA ONCOLOGY COM 50127T109 11,444 -2,159 -15.87 214 -24.65 0.0001
2021-08-13 2021-06-30 13F KURA ONCOLOGY COM 50127T109 13,603 -44,396 -76.55 284 -82.68 0.0001
2021-05-12 2021-03-31 13F KURA ONCOLOGY COM 50127T109 57,999 51,012 730.10 1,640 619.30 0.0005
2021-02-11 2020-12-31 13F KURA ONCOLOGY COM 50127T109 6,987 1,353 24.01 228 31.79 0.0001
2020-11-12 2020-09-30 13F KURA ONCOLOGY COM 50127T109 5,634 5,385 2,162.65 173 4,225.00 0.0001
2020-07-31 2020-06-30 13F KURA ONCOLOGY COM 50127T109 249 -16,301 -98.50 4 -97.58 0.0000
2020-05-01 2020-03-31 13F KURA ONCOLOGY COM 50127T109 16,550 -14,619 -46.90 165 -61.54 0.0001
2020-02-14 2019-12-31 13F KURA ONCOLOGY COM 50127T109 31,169 -47,500 -60.38 429 -64.07 0.0001
2019-11-14 2019-09-30 13F KURA ONCOLOGY COM 50127T109 78,669 76,917 4,390.24 1,194 3,311.43 0.0005
2019-08-14 2019-06-30 13F KURA ONCOLOGY COM 50127T109 1,752 1,752 35 0.0000
2019-05-14 2019-03-31 13F KURA ONCOLOGY COM 50127T109 0 -50,275 -100.00 0 -100.00
2019-02-14 2018-12-31 13F KURA ONCOLOGY COM 50127T109 50,275 43,281 618.83 705 477.87 0.0003
2018-11-14 2018-09-30 13F KURA ONCOLOGY COM 50127T109 6,994 6,994 122 0.0000
2018-08-14 2018-06-30 13F KURA ONCOLOGY COM 50127T109 0 -30,671 -100.00 0 -100.00
2018-05-15 2018-03-31 13F KURA ONCOLOGY COM 50127T109 30,671 18,171 145.37 575 201.05 0.0002
2018-02-14 2017-12-31 13F KURA ONCOLOGY COM 50127T109 12,500 -2,704 -17.78 191 -15.86 0.0001
2017-11-14 2017-09-30 13F KURA ONCOLOGY COM 50127T109 15,204 15,204 227 0.0001
2017-11-14 2017-06-30 13F/A-1 KURA ONCOLOGY COM 50127T109 0 -2,639 -100.00 0 -100.00
2017-11-14 2017-03-31 13F/A-1 KURA ONCOLOGY COM 50127T109 2,639 872 49.35 23 130.00 0.0000
2017-05-12 2017-03-31 13F KURA ONCOLOGY COM 50127T109 2,639 872 23
2017-02-14 2016-12-31 13F KURA ONCOLOGY COM 50127T109 1,767 -1,864 -51.34 10 -56.52 0.0000
2016-11-14 2016-09-30 13F KURA ONCOLOGY COM 50127T109 3,631 3,631 0.00 23 0.0000
2016-08-12 2016-06-30 13F KURA ONCOLOGY COM 50127T109 0 -1,184 -100.00 0 -100.00
2016-05-12 2016-03-31 13F KURA ONCOLOGY COM 50127T109 1,184 1,184 5 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.